Corporate Information And Statement Of Ifrs Compliance [Abstract]

Egetis Therapeutics - Filing #5995613

Concept	As at 2024-12-31	2024-01-01 to 2024-12-31	As at 2023-12-31
Corporate information and statement of IFRS compliance [abstract]
Name of reporting entity or other means of identification	—	Egetis Therapeutics AB (publ)	—
Legal form of entity	—	publikt aktiebolag	—
Address of entity's registered office	—	Klara Norra kyrkogata 26, 111 22 Stockholm	—
Principal place of business	—	Sverige	—
Description of nature of entity's operations and principal activities	—	ALLMÄNT OM VERKSAMHETEN	—
Statement of IFRS compliance [text block]	—	Grund för rapporternas upprättande	—
Disclosure of reclassifications or changes in presentation [text block]	—	NOT 5	—
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [text block]	—	—	—
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [abstract]
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [line items]
Current inventories	10,000,000 SEK	—	7,000,000 SEK
Current trade receivables	155,000,000 SEK	—	282,000,000 SEK
Current trade payables	257,000,000 SEK	—	287,000,000 SEK
Disclosure of material accounting policy information [text block]	—	NOT 2	—